Cargando…

The TAS1R2 sweet taste receptor regulates skeletal muscle mass and fitness

Muscle fitness and mass deteriorate under the conditions of obesity and aging for reasons yet to be fully elucidated. Herein, we describe a novel pathway linking peripheral nutrient sensing and skeletal muscle function through the sweet taste receptor TAS1R2 and the involvement of ERK2-PARP1-NAD sig...

Descripción completa

Detalles Bibliográficos
Autores principales: Serrano, Joan, Boyd, Jordan, Mason, Carter, Smith, Kathleen R, Karolyi, Katalin, Kondo, Saki, Brown, Ian S, Maurya, Santosh K, Meshram, Nishita N, Serna, Vanida, Gilger, Joshua, Branch, Daniel A, Gardell, Stephen J, Baskin, Kedryn K, Ayala, Julio E, Pratley, Richard E, Goodpaster, Bret H, Coen, Paul M, Kyriazis, George A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934781/
https://www.ncbi.nlm.nih.gov/pubmed/36798161
http://dx.doi.org/10.21203/rs.3.rs-2475555/v1
Descripción
Sumario:Muscle fitness and mass deteriorate under the conditions of obesity and aging for reasons yet to be fully elucidated. Herein, we describe a novel pathway linking peripheral nutrient sensing and skeletal muscle function through the sweet taste receptor TAS1R2 and the involvement of ERK2-PARP1-NAD signaling axis. Muscle-specific deletion of TAS1R2 (mKO) in mice produced elevated NAD levels due to suppressed PARP1 activity, improved mitochondrial function, increased muscle mass and strength, and prolonged running endurance. Deletion of TAS1R2 in obese or aged mice also ameliorated the decline in muscle mass and fitness arising from these conditions. Remarkably, partial loss-of-function of TAS1R2 (rs35874116) in older, obese humans recapitulated the healthier muscle phenotype displayed by mKO mice in response to exercise training. Our findings show that inhibition of the TAS1R2 signaling in skeletal muscle is a promising therapeutic approach to preserve muscle mass and function.